These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5559346)

  • 1. [Isolation, purification and some properties of antiviral substances from the yeast].
    Kovalenko AG
    Mikrobiol Zh; 1971; 33(1):75-82. PubMed ID: 5559346
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antiviral substances produced by Candida tropicalis K-41 yeasts. I. The isolation, purification and antiviral activity of the preparations].
    Kovalenko AG
    Mikrobiol Zh; 1978; 40(1):85-91. PubMed ID: 634175
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antiviral properties of a yeast extract].
    Kovalenko AG
    Mikrobiol Zh; 1970; 32(3):398-400. PubMed ID: 5517390
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the action of yeast polysaccharides of different structures on the tobacco mosaic virus].
    Kovalenko AG; Barkalova AA; Koloshin VG; Vitovskaia GA; Elinov NP
    Mikrobiol Zh; 1974; 36(4):490-7. PubMed ID: 4465682
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reactivation of the tobacco mosaic and potato X viruses inactivated by yeast-derived substances].
    Kovalenko AG; Bobyr' AD
    Mikrobiol Zh; 1973; 35(4):461-7. PubMed ID: 4779957
    [No Abstract]   [Full Text] [Related]  

  • 6. Purification and some properties of an extracellular ribonuclease with antiviral activity against tobacco mosaic virus from Bacillus cereus.
    Zhou WW; Niu TG
    Biotechnol Lett; 2009 Jan; 31(1):101-5. PubMed ID: 18777010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of the products of the vital activity of yeasts on the tobacco mosaic virus].
    Bobyr' AD; Glushak LE
    Mikrobiol Zh; 1965; 27(2):73-8. PubMed ID: 5869334
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of tobacco mosaic virus by a bacterial extract.
    Mann EW
    Phytopathology; 1969 May; 59(5):658-62. PubMed ID: 5786563
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antiviral substances from Saccharomyces cerevisiae and Sacch. carlsbergensis yeasts].
    Kovalenko AG; Bobyr' AD; Votselko SK; Diachok VV
    Mikrobiol Zh; 1974; 36(2):191-6. PubMed ID: 4619159
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemical nature and properties of an inhibitor of tobacco mosaic virus isolated from Pseudomonas longa (Zimm.) Migula].
    Iazykova TF; Mozhaeva KA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1973; 115(7):100-2. PubMed ID: 4770222
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antiphytoviral activity of capsule substances of Cryptococcus albidus yeast].
    Kovalenko OH; Barkalova AO; Nahorrna SS
    Mikrobiol Z; 2005; 67(3):81-4. PubMed ID: 16018209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular weight and several features of the structure of yeast polysaccharides possessing antiviral properties].
    Kovalenko AG; Votselko SK
    Prikl Biokhim Mikrobiol; 1977; 13(1):46-54. PubMed ID: 325548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tobacco mosaic virus (TMV) triterpenoid saponins from the leaves of Ilex oblonga.
    Wu ZJ; Ouyang MA; Wang CZ; Zhang ZK; Shen JG
    J Agric Food Chem; 2007 Mar; 55(5):1712-7. PubMed ID: 17274628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and properties of antiviral proteins from the leaves of Bougainvillea xbuttiana.
    Narwal S; Balasubrahmanyam A; Lodha ML; Kapoor HC
    Indian J Biochem Biophys; 2001 Oct; 38(5):342-7. PubMed ID: 11886084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening of proteins anti-tobacco mosaic virus in Pleurotus eryngii].
    Fu M; Lin J; Wu Z; Lin Q; Xie L
    Wei Sheng Wu Xue Bao; 2003 Feb; 43(1):29-34. PubMed ID: 16276868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Physico-chemical properties of antiviral preparations obtained from the yeast].
    Moskovets SN; Kovalenko AG; Votselko SK
    Mikrobiol Zh; 1971; 33(1):82-8. PubMed ID: 5559348
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nature of the action of Candida tropicalis K-41 mannan on tobacco mosaic virus infectivity].
    Kovalenko AG; Barkalova AA; Bobyr' AD; Votselko SK
    Mikrobiol Zh (1978); 1981; 43(5):627-32. PubMed ID: 7311897
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study of the action of Candida tropicalis K-41 polysaccharides on the infectivity of the tobacco mosaic virus and its RNA].
    Kovalenko AG; Barkalova AA; Mikheeva II
    Mikrobiol Zh (1978); 1981; 43(5):633-9. PubMed ID: 7311898
    [No Abstract]   [Full Text] [Related]  

  • 19. Discovery of bitriazolyl compounds as novel antiviral candidates for combating the tobacco mosaic virus.
    Xia Y; Fan Z; Yao J; Liao Q; Li W; Qu F; Peng L
    Bioorg Med Chem Lett; 2006 May; 16(10):2693-8. PubMed ID: 16504509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of laurusin (formycin B) on tobacco mosaic virus multiplication and its symptom development.
    Huang KT; Katagiri M; Misato T
    J Antibiot (Tokyo); 1966 Mar; 19(2):75-7. PubMed ID: 5952895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.